Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Andrea Marcellusi1, Chiara Bini2, Laura Fioravanti3

  • 1Department of Pharmaceutical Sciences - DISFARM, University of Milan, Milan - Italy.

Global & Regional Health Technology Assessment
|May 7, 2025
PubMed
Summary

No abstract available in PubMed .

Keywords:
Brentuximab VedotinCost-effectiveness analysisEconomic evaluationSystemic anaplastic large cell lymphomasALCL

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost minimization analysis of subcutaneous and intravenous immunoglobulin treatment in Italy.

Global & regional health technology assessment·2026
Same author

The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy.

Global & regional health technology assessment·2026
Same author

Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum.

Journal of market access & health policy·2025
Same author

Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies.

BMJ public health·2025
Same author

Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants.

Clinical drug investigation·2025
Same author

Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy.

Global & regional health technology assessment·2025
Same journal

Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.

Global & regional health technology assessment·2026
Same journal

Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.

Global & regional health technology assessment·2026
Same journal

Comments on: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.

Global & regional health technology assessment·2026
Same journal

Author's reply to comments to: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.

Global & regional health technology assessment·2026
Same journal

Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.

Global & regional health technology assessment·2026
Same journal

Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma.

Global & regional health technology assessment·2026
See all related articles